Nina Teresa Gentile MD

Emergency Medicine•Philadelphia, PA

Professor and Vice Chair for Research Department of Emergency Medicine, Temple University School of Medicine

Join to View Full Profile

3401 N Broad StTemple University HospitalPhiladelphia, PA 19140
Phone+1 215-707-8402
Fax+1 215-707-3494

Education & Training

Henry Ford Health/Henry Ford HospitalResidency, Emergency Medicine, 1986 - 1989
MCP-Hahnemann College of MedicineClass of 1986

Certifications & Licensure

PA State Medical License 1997 - 2026
CT State Medical License 1989 - 1993
MI State Medical License 1986 - 1990
American Board of Emergency Medicine Emergency Medicine

Clinical Trials

Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study Start of enrollment: 2001 Oct 01
Completed
High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2009 Sep 01
Withdrawn
Not Applicable
The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department
Completed
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Start of enrollment: 2012 Apr 01
Completed
Phase 3
LIPS-A: Lung Injury Prevention Study With Aspirin Start of enrollment: 2012 Jan 01
Completed
Phase 2
Study of Procoagulation Markers in Stroke Patients Start of enrollment: 2012 Aug 01
Completed
Multi-arm Optimization of Stroke Thrombolysis Start of enrollment: 2019 Oct 15
COMPLETED
PHASE3
Roles: Contact
ARrest RESpiraTory Failure From PNEUMONIA Start of enrollment: 2020 Jun 01
RECRUITING
PHASE3
Roles: Principal Investigator, Contact
ACTIV-6: COVID-19 Study of Repurposed Medications Start of enrollment: 2021 Jun 08
COMPLETED
PHASE3
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation Start of enrollment: 2007 Mar 01
Completed
Phase 4
Emergency Department-Initiated Buprenorphine Validation Network Trial Start of enrollment: 2020 Jul 08
COMPLETED
PHASE2
Roles: Contact
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Start of enrollment: 2021 Dec 03
RECRUITING
PHASE3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.
Sean P Collins, Matthew S Shotwell, Jeffrey R Strich, Kevin W Gibbs, Marjolein de Wit
JAMA Network Open. 2024-12-02
1 citations
Heart rate variability wrist-wearable biomarkers identify adverse posttraumatic neuropsychiatric sequelae after traumatic stress exposure.
Lauriane Guichard, Xinming An, Thomas C Neylan, Gari D Clifford, Qiao Li
Psychiatry Research. 2024-12-01
1 citations
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, David R Boulware, Matthew W McCarthy
JAMA Network Open. 2024-10-01

Press Mentions

Temple University Hospital to Study Experimental Stroke DrugNovember 10th, 2022
How Johnson & Johnson’s COVID-19 Vaccine Is Different from Pfizer’s and Moderna’sFebruary 26th, 2021
Johnson & Johnson – COVID Replace: Temple College Docs Search Philadelphians to Check Johnson & Johnson One-Dose COVID-19 VaccineNovember 21st, 2020
Join now to see all

Grant Support

Temple Strategies to Innovate EmeRgENcy Care Clinical Trials Network (Temple-SIREN)TEMPLE UNIV OF THE COMMONWEALTH2017–2028

Nina Teresa Gentile MD

Dr. Gentile is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.